StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
Huagongshe Open Project:[email protected]KI-Anbindung: llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.7.8
Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 4879Erstellt: 4. November 2026

4-Amino-1-phenylpyrazolo(3,4-d)pyrimidine

Inetetamab · PP3 · Amino d · NSC 1401 · PP-3 · PP 3 · PP 3, 10 mM in DMSO · PP3 ISO 9001:2015 REACH

https://huagongshe.com/de/chemical/4879

Molekülstruktur von 4-Amino-1-phenylpyrazolo(3,4-d)pyrimidine

Identifikatoren & physikalische Daten

CAS No.5334-30-5
SummenformelC11H9N5
Durchschnittliche Molmasse211,22 g/mol
Monoisotopische Masse211,08579531 g/mol
SMILESNc1ncnc2c1cnn2-c1ccccc1
InChIKeyKKDPIZPUTYIBFX-UHFFFAOYSA-N
PubChem CID4879
ChEMBLCHEMBL65063
ChEBICHEBI:92303
EC No.808-056-5
DTXSIDDTXSID20274448

Chemische & physikalische Eigenschaften

XLogP1,5
Polarare Oberfläche (TPSA)69,6
H-Brücken-Donoren1
H-Brücken-Akzeptoren4
Frei drehbare Bindungen1
Schwere Atome16
Formalladung0
Komplexität241
Schmelzpunkt214-217 °C
Siedepunkt363.952±35.00 °C(Press: 760.00 Torr)(predicted)
Dichte1.448±0.14 g/cm3(Temp: 25 °CPress: 760 Torr)(predicted)
Lagerbedingungen-20°C
LöslichkeitDMF, DMSO, Hot methanol
pKa (Säurekonstante)3.89
AggregatzustandOff-white solid
FarbeWhit to Off-White
BRN198460
CAS Datenbank5334-30-5(CAS DataBase Reference)

Sicherheit & Vorschriften

GHS-EinstufungWarningH315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.
Hazard Classes and CategoriesSkin Irrit. 2 (100%)
Zollcode29335995
R-Sätze (R)36/37/38-22
GefahrensymboleXn,Xi
hazard_noteIrritant
Sicherheitshinweise (S)36/37/39-26

Anwendungen & Verwendung

Verwenden

The Src family of non-receptor tyrosine kinases regulate cell adhesion, growth, and differentiation through activation of multiple intracellular signaling pathways. Normally inactive, Src kinases are transiently activated during mitosis and constitutively activated by abnormal mutations. Several small molecule inhibitors of this signaling pathway have been developed as a therapeuptic strategy to abate abnormal Src kinase activity. PP3 is an inactive analog of the Src tyrosine kinase inhibitors PP1 and PP2 . At concentrations as high as 10 μM, it does not prevent proliferation mediated by a stem cell factor/mast cell growth factor in hematopoietic and cancer cell lines.[Cayman Chemical]